LMP7 and LMP2 or LMP7 and MECL-1 have to be co-inhibited to ameliorate rheumatoid arthritis, inflammatory colitis, and experimental autoimmune encephalomyelitis in animal models [98,99] (summarized in [51]). Here, PSMB8 is linked to experimental autoimmune encephalomyelitis.